ALK-Abelló A/S (CPH:ALK.B)
Denmark · Delayed Price · Currency is DKK 220.60
-3.40 (-1.52%)
Aug 10, 2026, 4:59 PM CET
ALK-Abelló Market Cap
ALK-Abelló has a market cap or net worth of 49.01 billion as of August 10, 2026. Its market cap has increased by 24.41% in one year.
Market Cap
49.01B
Enterprise Value
47.87B
Revenue
6.56B
Ranking
n/a
PE Ratio
38.28
Stock Price
220.60
ChartMarket Cap Chart
Since December 27, 2005, ALK-Abelló's market cap has increased from 6.91B to 49.01B, an increase of 609.46%. That is a compound annual growth rate of 9.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 49.01B | -3.07% |
| Dec 30, 2025 | 50.56B | 43.68% |
| Dec 30, 2024 | 35.19B | 57.21% |
| Dec 29, 2023 | 22.38B | 5.48% |
| Dec 30, 2022 | 21.22B | -43.63% |
| Dec 30, 2021 | 37.65B | 37.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.35T |
| Genmab | 119.34B |
| Coloplast | 98.51B |
| Demant | 59.52B |
| H. Lundbeck | 40.02B |
| Zealand Pharma | 23.25B |
| Ambu A/S | 19.37B |
| GN Store Nord | 14.39B |